These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 15686175

  • 1. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T.
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [Abstract] [Full Text] [Related]

  • 2. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system.
    Sasaki T, Kodama N, Kawakami M, Sato M, Asari J, Sakurai Y, Watanabe K, Onuma T, Matsuda T.
    Stroke; 2000 Jun; 31(6):1256-62. PubMed ID: 10835441
    [Abstract] [Full Text] [Related]

  • 3. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.
    Kodama N, Sasaki T, Kawakami M, Sato M, Asari J.
    Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Moriyama E, Matsumoto Y, Meguro T, Kawada S, Mandai S, Gohda Y, Sakurai M.
    Neurol Med Chir (Tokyo); 1995 Oct; 35(10):732-6. PubMed ID: 8532128
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K, Kamata I, Hirotsune N, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T, Mandai S, Matsumoto Y.
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T, Esaki T, Nakao Y, Mori K.
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [Abstract] [Full Text] [Related]

  • 12. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM, Weir BK, Kassell NF, Disney LB, Grace MG.
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [Abstract] [Full Text] [Related]

  • 13. Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage.
    Otawara Y, Ogasawara K, Kubo Y, Sasoh M, Ogawa A.
    Vasc Health Risk Manag; 2007 Aug; 3(4):401-4. PubMed ID: 17969369
    [Abstract] [Full Text] [Related]

  • 14. Impact of ventriculo-cisternal irrigation on prevention of delayed cerebral infarction in aneurysmal subarachnoid hemorrhage: a single-center retrospective study and literature review.
    Umekawa M, Yoshikawa G.
    Neurosurg Rev; 2023 Dec 08; 47(1):6. PubMed ID: 38062206
    [Abstract] [Full Text] [Related]

  • 15. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T, Mori K, Esaki T, Nakao Y, Tokugawa J, Watanabe M.
    J Neurosurg; 2016 Jan 08; 124(1):18-26. PubMed ID: 26230471
    [Abstract] [Full Text] [Related]

  • 16. Surgical procedure and results of cisternal washing therapy for the prevention of cerebral vasospasm following SAH.
    Nakagomi T, Furuya K, Nagashima H, Tanaka J, Ishii T, Takanashi S, Shinohara T, Watanabe F, Ogawa A, Fujii N, Tamura A.
    Acta Neurochir Suppl; 2011 Jan 08; 110(Pt 2):105-9. PubMed ID: 21125454
    [Abstract] [Full Text] [Related]

  • 17. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
    Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A, Koshu K.
    Neurosurgery; 1991 Jun 08; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
    [Abstract] [Full Text] [Related]

  • 18. [Preventive effect on intracranial arterial vasospasm using combined ventriculo-cisternal and cisternal drainage (author's transl)].
    Sonobe M, Takahashi S, Otsuki T, Kubota Y.
    No Shinkei Geka; 1981 Nov 08; 9(12):1393-7. PubMed ID: 7322267
    [Abstract] [Full Text] [Related]

  • 19. Effect of continuous cisternal drainage on cerebral vasospasm.
    Inagawa T, Kamiya K, Matsuda Y.
    Acta Neurochir (Wien); 1991 Nov 08; 112(1-2):28-36. PubMed ID: 1763681
    [Abstract] [Full Text] [Related]

  • 20. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T, Kazekawa K, Nakashima S, Kohno H, Tanaka N, Honma T, Kaneko Y, Satoh K.
    Int J Clin Pharmacol Ther; 1995 Sep 08; 33(9):513-7. PubMed ID: 8520810
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.